ArticleFrontiers in pharmacology2019

Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis.

Joseph Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.